MARATTO

article · Chemistry & Biodiversity

Evaluation of the Phenolic Profile, Antioxidant, and Anti‐Gout Effects of Three Aerial Parts of the Algerian Herb <i>Diplotaxis harra</i>

Abstract

This study investigated the phenolic profile, antioxidant capacity, and anti-gout potential of methanolic extracts obtained from flowers, leaves, and stems of Diplotaxis harra subsp. crassifolia. Total phenolic and flavonoid contents were quantified spectrophotometrically, and individual phenolics were characterized by LC-MS/MS, revealing 15 compounds in flowers, 11 in leaves, and 7 in stems, with quinic acid as the predominant constituent. Antioxidant activity was evaluated using DPPH, ABTS, CUPRAC, FRAP, phosphomolybdenum, and metal-chelation assays, in which flower extracts consistently exhibited the highest antioxidant potential. Xanthine oxidase (XO) enzyme inhibition assay revealed that the flower extract exhibited the best inhibition activity, with an IC<sub>50</sub> of 0.212 mg/mL, comparable to that of the positive control allopurinol (0.25 mg/mL). Consistently, molecular docking showed that gentisic and protocatechuic acids, most phenolics in the extract, bind XO with more favorable energies than allopurinol through extensive hydrogen-bonding and hydrophobic interactions at key active site residues. Overall, this initial organ-specific evaluation of D. harra provides strong support for its flower extracts as promising candidates for standardized anti-gout preparations and as scaffolds for future XO inhibitor development.

Research topics

  • Gout, Hyperuricemia, Uric Acid
  • Natural product bioactivities and synthesis
  • Natural Compound Pharmacology Studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/cbdv.202503139

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.